Amlodipine, Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 65862-835

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Amlodipine, Valsartan And Hydrochlorothiazide (NDC 65862-835). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Amlovalhctz Fig1)

This appears to be medical information describing dosages and combinations of medications used to treat hypertension.*

FDA Label Image

Package Label-principal Display Panel (10 mg/320 mg/25 mg (30 Tablets Bottle))

This appears to be a description of a medication called Amlodipine, Valsartan, and Hydrochlorothiazide which comes in a bottle labeled "Exchfimcostd bl comtalns" with a dosage of "Dt B8z 838.80 ooy 5P oo Prama U". The medication is in tablet form, with a label "Tablets USP Tl I i" and a code of "Cot: TS/DRUGS/2222000" and "P1422175". The label also mentions to keep the medication in a safe place and not to use past the expiration date. The bottle appears to be manufactured by Aurobindo, but there is a pending test for organic impurities.*

FDA Label Image

Figure2 (Amlovalhctz Fig2)

FDA Label Image

Figure3 (Amlovalhctz Fig3)

This is a tabular form showing Mean Siting SBP (mmHg) values ranging from 120 to 180. There are six weeks of data displayed on the horizontal axis with corresponding treatments listed underneath. The treatments include Amlodipine/Valsartan/Hydrochlorothiazide 10mg/320mg/25mg, Amlodipine/Valsartan 10mg/320mg, Valsartan/Hydrochlorothiazide 320mg/25mg and Hydrochlorothiazide/Amlodipine 25mg/10mg.*

FDA Label Image

Figure4 (Amlovalhctz Fig4)

FDA Label Image

Figure5 (Amlovalhctz Fig5)

This is a graph showing the mean Ambulatory SBP (Systolic Blood Pressure) over time, up to 24 hours after dosing with different treatments. The treatments include a combination of Amlodipine, Valsartan, and Hydrochlorothiazide in different doses. The graph compares three different treatment options. The x-axis shows Hours after Dosing, and the y-axis shows the SBP values. It is useful for comparing the efficacy of different antihypertensive treatments.*

FDA Label Image

Package Label-principal Display Panel (5 mg/160 mg/12.5 mg (30 Tablets Bottle))

A combination medication containing Amlodipine, Valsartan, and Hydrochlorothiazide is available in the form of tablets. It is manufactured by Aurobindo and each tablet contains 5 mg/160 mg/12.5 mg of the medicines respectively. The product has a unique identifier number. The rest of the text does not appear to be useful information.*

FDA Label Image

Package Label-principal Display Panel -10 mg/160 mg/12.5 mg (30 Tablets Bottle) (Amlovalhctz Fig7)

FDA Label Image

Package Label-principal Display Panel (5 mg/160 mg/25 mg (30 Tablets Bottle))

This appears to be a partial description of pharmaceutical products. It includes the name of a drug "Amlodipine, Valsartan, and Hydrochlorothiazide Tablets USP" and some of its specifications, such as weight and storage conditions. The text also includes a manufacturer's name and address. However, the content is not clear and complete enough to provide a useful description in its current form.*

FDA Label Image

Package Label-principal Display Panel (10 mg/160 mg/25 mg (30 Tablets Bottle))

FDA Label Image

Amlodipine Molecular Structure (Amlovalhctz Str1)

FDA Label Image

Valsartan Molecular Structure (Amlovalhctz Str2)

FDA Label Image

Hydrochlorothiazide Molecular Structure (Amlovalhctz Str3)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.